{"name":"MyMD Pharmaceuticals","slug":"mymd","ticker":"MYMD","exchange":"NASDAQ","domain":"mymdpharma.com","description":"MyMD Pharmaceuticals is a biopharmaceutical company focused on developing treatments for autoimmune and aging-related diseases. The company's lead product, MYMD-1, is a small molecule that has shown promise in preclinical studies for its potential to treat various autoimmune and inflammatory conditions. MYMD Pharmaceuticals is positioning itself as a leader in the autoimmune and aging therapeutic areas. The company's pipeline is still in its early stages, but it has the potential to disrupt the market with its innovative approach.","hq":"Tampa, FL","founded":0,"employees":"","ceo":"Chris Chapman, MD","sector":"Autoimmune / Aging","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"$35M","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[{"date":"2024-02-28","type":"earnings","headline":"MyMD Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results","summary":"MyMD Pharmaceuticals reported its financial results for the fourth quarter and full year 2023, highlighting its progress in developing its pipeline of treatments for autoimmune and aging-related diseases.","drugName":"","sentiment":"neutral"},{"date":"2023-11-14","type":"deal","headline":"MyMD Pharmaceuticals Announces Collaboration with Leading Research Institution","summary":"MyMD Pharmaceuticals announced a collaboration with a leading research institution to advance its research in the field of autoimmune and aging-related diseases.","drugName":"","sentiment":"positive"}],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxOZHUzcVY1SFhpMHlTSm9JUVplcWtqYnJaUkpESjZsZy03MktOemMzMWFpemlzSTdSRkdEVFdFSXBHQllxTzhfQWFIWm9tWTBsQm1rOFNCOUQ1UzlyelFYTm1idkZOdlZfU3hibERWUmEtbG1BTVFKc2FKVEtvV3RBdTRuSFo2WTlHUFNJYjBvbmt0Sno4bHdzXzd5N3VvRUZNOU9jcy1uSnVEOXVEZnBCd3ppNFBjZWZnZUE?oc=5","date":"2026-03-23","type":"pipeline","source":"AD HOC NEWS","summary":"MyMD Pharmaceuticals stock faces renewed scrutiny amid strategic investments and biotech sector vola - AD HOC NEWS","headline":"MyMD Pharmaceuticals stock faces renewed scrutiny amid strategic investments and biotech sector vola","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTFBPa1RlZUsxb1gzSTFqVkNUMXM1M1cwbWtWSE1INjFXdUNWbFJCa1I5V3ozZmt6Y1VWRjlhcThTaFNzdEZKQWlXMEJDYThIMnhXTnBF?oc=5","date":"2025-04-25","type":"pipeline","source":"Stock Titan","summary":"MyMD Pharmaceuticals Stock Price, News & Analysis - Stock Titan","headline":"MyMD Pharmaceuticals Stock Price, News & Analysis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxOcGpVMzNFSjVnSXF5aEFvdGF5cUIzZC00RFUxYXhFbmJZVmlDQUxjOXlkbW5VNmxXMFBQcm8zeFhmLUZhNVVKV0VGYy1Ob05ubGd3UHJPLUVhTGcyWG9VZ2VGSHdhcmFBTVZwWS1zR28tYmdhb3VaME1fTlFSNWU2WFE5VGRpcEdObkV5X1gwc3dTdUZvb2tr?oc=5","date":"2024-07-23","type":"pipeline","source":"Fierce Pharma","summary":"MyMD Pharmaceuticals is no more: Meet TNF Pharmaceuticals - Fierce Pharma","headline":"MyMD Pharmaceuticals is no more: Meet TNF Pharmaceuticals","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3gFBVV95cUxNRi10R2owOW9rSE5nMnEwaklKS3lxLXh5c1E2Mnc4OXdNWHN6U1FKaElRemwxY2RkUktyOGJwZS1QTHMwbHYzN0tzNVpVcjFTU2Z0dlhmc2s3Qmg3eTZwdndJZ1BKanh6N2F6SUNnclF6NU11RVlnZjQwU29KRklUZVJRRVY3bF9MWFRRejA5Zm5RWk42LVc2NXVRRW1seWxxY2NKZ3FJMWdNMnIxTnhGRy1YSU1kV3ZaRDRVVFR5b25fcmszX05hSzNaeHk2b19TcVBJa09veC1tTU5DQ2c?oc=5","date":"2024-07-22","type":"pipeline","source":"Business Wire","summary":"MyMD Pharmaceuticals Announces Corporate Rebranding to New Name TNF Pharmaceuticals, Inc. - Business Wire","headline":"MyMD Pharmaceuticals Announces Corporate Rebranding to New Name TNF Pharmaceuticals, Inc.","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMidEFVX3lxTE52UWRjLWFDVmhLdHdxLTl1bnQ5OS1QeHcwYTQ1aDFSUS0xcFFaVXBzTFl4RXUwYWp0NkNBbVkxbHR3dXdtNjExVEN5NTk4MDFNcjN0MXF2eVk1dUJJY1gzOWpBMW0wZ181Ukt3aXdoNElUc0tL?oc=5","date":"2024-06-27","type":"pipeline","source":"The Pharma Letter","summary":"MyMD Pharmaceuticals | Biotechnology | The Pharmaletter - The Pharma Letter","headline":"MyMD Pharmaceuticals | Biotechnology | The Pharmaletter","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgJBVV95cUxPSWZZck5wS3BtdEZfZkhycVVickZyakRyNGxIYkQydk9HQlpvSmZ5RmRtOTFhS2NIQXlWVjlZdDl1RVpFNkpKQU1nUWdLVHYwREpPa0RQQ2VmRTllMHdiYzdjQWdJdmxRSGx6cDlTUnYwYU84SXI2UnhiOXVuSHpuczR6LXN3TVFXUDQzcXRCdG82OVQ2QTM1aE5aRnpHZEdVbUtYb2xkaUpKQ0xJOEhVc0pzbi1HV3hleHhyVDNuZ21ncVVqa2ZYdzMzcjBDaV9EX3lvMXpGSF94cnVVNS03VEIwczByMXUzYVhfVkMtTHFMaENlUnZ5OElXeFNkZVIzeEVCLVI2WFNnSzBfa1BlYVliTVNEZ0VDMlVxaGczQ3VTNlFzTmVmRXF0eW5YUjFlamc?oc=5","date":"2024-06-17","type":"pipeline","source":"Business Wire","summary":"MyMD Pharmaceuticals Appoints Accomplished Biopharmaceutical Leader and Current Board Member, Mitchell Glass, M.D. as President and Chief Medical Officer - Business Wire","headline":"MyMD Pharmaceuticals Appoints Accomplished Biopharmaceutical Leader and Current Board Member, Mitchell Glass, M.D. as Pr","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxNMnhnYTFLRnAwcmpoWXQzdDlZWVJQQnFpT3RxSThmclBtcXpEaUl2ZFR1X3hJYktPbFk1ZE4wRENNdC00NVhveGg3MTBiT1pwNlF6YkswV25EMDdicmpQNnI3cUt6Y0hEZGpuUlRsd3U2RzNxVWtVenc5VEdFT1BFaVpQY0o0N2dqbFlZN0ZGRXl5MmJwM1FzcThPU2Fqam1Ec2Q3MHlRbC1ZdWs?oc=5","date":"2024-05-21","type":"pipeline","source":"Business Wire","summary":"MyMD Pharmaceuticals Secures Strategic Investments - Business Wire","headline":"MyMD Pharmaceuticals Secures Strategic Investments","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwJBVV95cUxQSDZOYUhQSXNDZi1WSGF4VkZKbkVqajRTTmtZVHBISWhBUmlZMEpKVjV2VnY1cTdTV3dRNTB1dFYyNldCbDNVM1lJd3ZIWGhKODhSRUZrOUk4dTdtdlFiSlE3dWUwSi1oNTFScWJGY2NaRWk1WUU0bllySlEteDRXc3VSWkJjbGljbzB6Z0hCQ3BtMDFkbmtWNXk3Y1RmTzg1MWJzbjhuUHdGbXducHozejdTYldUR2o2R094N1ZXN05ycjRLMWhPLUNvand6NUY4T3BLLWFOTENZc0VybWNrdW9ocEpZY0pQdHktRlBWMll3WjNvSXhZU05pNWlGZ2FjTHFuaG82eG0zZkpna09j?oc=5","date":"2024-05-21","type":"pipeline","source":"FinancialContent","summary":"PharmaCyte Biotech Makes $7 Million Strategic Investment in MyMD, A Biopharmaceutical Company Focused on Inflammatory Disease - FinancialContent","headline":"PharmaCyte Biotech Makes $7 Million Strategic Investment in MyMD, A Biopharmaceutical Company Focused on Inflammatory Di","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_AFBVV95cUxNTEZvOUo5OFk3OWlTUFlxU3hVaWhmZjJ5UjJTdGNxdnFEVl9Qbzh1ak9ncDJpYThRaXNiN3dPemdUNUlMQTdwTUgwVzcxOWJjNUlCUjFrbi12TGp0WWdGbngwa0QtMkhsYTRGZTBlcE4wd3EzRGxaVGVBZUU0OGQzV2EwVkhsRmJ3NXo5UFQya2NmUFFlZGJuTzdVNzhKalN0THRtdXpMeEFRalJZbnY5V3NFbkhFZFY1RnNMTTRIZElpeFoxSGpUVUVxM2QxMUp3MTVqT0dzazd4MVBuX0FubVRfbkw4NGlPVFFyYWJGTFVwR3NsVnhzTWM3d0E?oc=5","date":"2021-10-26","type":"pipeline","source":"Business Wire","summary":"MyMD Pharmaceuticals President Chris Chapman, M.D. Named Medical Honoree of the Year by the Arthritis Foundation - Business Wire","headline":"MyMD Pharmaceuticals President Chris Chapman, M.D. Named Medical Honoree of the Year by the Arthritis Foundation","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE1VdzJxUzg2RXBLWmh1OU9hMlZBdThHRmp2cjdDc1ZuRVZEb05Wc2FtRjdkby1ab0J3TV90MlktQTNpXzZoTkVBa1czOWk2N0VaMXRma0tpMm42V21CRWM0?oc=5","date":"2021-06-06","type":"pipeline","source":"ChartMill","summary":"MYMD Stock Price, Quote & Chart | MYMD PHARMACEUTICALS INC (NASDAQ:MYMD) - ChartMill","headline":"MYMD Stock Price, Quote & Chart | MYMD PHARMACEUTICALS INC (NASDAQ:MYMD)","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":["Biohaven Pharmaceuticals","Pfizer","Eli Lilly and Company"],"therapeuticFocus":["Autoimmune Diseases","Aging-Related Diseases"],"financials":null,"yahoo":null}